
Phenotypic data from 328,973 participants enrolled in SPARK, including 132,138 individuals with ASD, are now available to approved researchers. Genomic data also is available for 116,693 SPARK participants, specifically 106,744 (44,304 ASD) with whole exome sequencing, and 12,519 (3,575 ASD) with whole genome sequencing. A total of 2,570 individuals have both.